The ‘Disappearing’ Liver on CEUS: Nothing to Worry About

by Thomas Müller, Friederike Posnien, Christoph Sarrazin
Published 2019-03-01

Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients.

by Julia Dietz, Simone Susser, Caterina Berkowski, Dany Perner, Stefan Zeuzem, Christoph Sarrazin
Published 2015-01-01

A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers.

by Johannes Vermehren, Jörn Lötsch, Simone Susser, Sabine Wicker, Annemarie Berger, Stefan Zeuzem, Christoph Sarrazin, Alexandra Doehring
Published 2012-01-01

Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.

by Simone Susser, Eva Herrmann, Christian Lange, Nabila Hamdi, Tobias Müller, Thomas Berg, Dany Perner, Stefan Zeuzem, Christoph Sarrazin
Published 2014-01-01

Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity.

by Martin-Walter Welker, David Reichert, Simone Susser, Christoph Sarrazin, Yolanda Martinez, Eva Herrmann, Stefan Zeuzem, Albrecht Piiper, Bernd Kronenberger
Published 2012-01-01

Oxidized Low-Density Lipoprotein Is a Novel Predictor of Interferon Responsiveness in Chronic Hepatitis C InfectionSummary

by Philipp Solbach, Sandra Westhaus, Maximilian Deest, Eva Herrmann, Thomas Berg, Michael P. Manns, Sandra Ciesek, Christoph Sarrazin, Thomas von Hahn
Published 2015-05-01

HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairm...

by Christoph Sarrazin, Michael Manns, Jose Luis Calleja, Javier Garcia-Samaniego, Xavier Forns, Renee Kaste, Xiaofei Bai, Jing Wu, Jerry O Stern
Published 2016-01-01

Serum sphingolipid levels associate with upcoming virologic events and HBV genotype D in a cohort of patients with HBeAg-negative HBV infection.

by Victoria Therese Mücke, Katja Jakobi, Viola Knop, Dominique Thomas, Marcus Maximilian Mücke, Kai-Henrik Peiffer, Stefan Zeuzem, Christoph Sarrazin, Josef Pfeilschifter, Georgios Grammatikos
Published 2018-01-01

SARS-CoV-2 neutralizing antibody therapies: an early retrospective cohort study of 26 hospitalized patients treated with bamlanivimab or casirivimab/imdevimab

by Martin Heller, Clara Henrici, Judith Büttner, Sebastian Leube, Isabelle Treske, Petra Pospischil, Michael Doll, Ilka Schanz, Agnes Hallier, Eva Herrmann, Michael Schmidt, Christoph Sarrazin
Published 2023-04-01

A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variants.

by Bambang S Adiwijaya, Eva Herrmann, Brian Hare, Tara Kieffer, Chao Lin, Ann D Kwong, Varun Garg, John C R Randle, Christoph Sarrazin, Stefan Zeuzem, Paul R Caron
Published 2010-04-01

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients

by Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht
Published 2019-03-01

Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)

by Bernhard Schlevogt, Klaus H. W. Boeker, Stefan Mauss, Hartwig Klinker, Renate Heyne, Ralph Link, Karl-Georg Simon, Christoph Sarrazin, Yvonne Serfert, Michael P. Manns, Heiner Wedemeyer
Published 2021-10-01

Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells.

by Verena Schlaphoff, Sebastian Lunemann, Pothakamuri Venkata Suneetha, Jerzy Jaroszewicz, Jan Grabowski, Julia Dietz, Fabian Helfritz, Hueseyin Bektas, Christoph Sarrazin, Michael Peter Manns, Markus Cornberg, Heiner Wedemeyer
Published 2011-05-01

Prediction of minimal residual viremia in HCV type 1 infected patients receiving interferon-based therapy

by Viola Knop, Gerlinde Teuber, Hartwig Klinker, Bernd Möller, Jens Rasenack, Holger Hinrichsen, Tilman Gerlach, Ulrich Spengler, Peter Buggisch, Konrad Neumann, Christoph Sarrazin, Stefan Zeuzem, Thomas Berg
Published 2013-03-01

Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and Faldaprevir.

by Kristi L Berger, Christoph Sarrazin, David R Nelson, Joseph Scherer, Nanshi Sha, Martin Marquis, Alexandra Côté-Martin, Richard Vinisko, Jerry O Stern, Federico J Mensa, George Kukolj
Published 2016-01-01

Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal

by Christoph Sarrazin, Christoph Boesecke, Solmaz Golsabahi‐Broclawski, Gero Moog, Francesco Negro, Carmina Silaidos, Polly Patel, Kristina Lohmann, Christoph D. Spinner, Stephan Walcher, Heiner Wedemeyer, Marcus‐Alexander Wörns
Published 2021-06-01

Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis.

by Benjamin Maasoumy, Bela Hunyady, Vincenza Calvaruso, Mihály Makara, Johannes Vermehren, Attila Haragh, Simone Susser, Birgit Bremer, Gavin Cloherty, Michael P Manns, Antonio Craxì, Heiner Wedemeyer, Christoph Sarrazin
Published 2014-01-01

PEG-IFN alpha but not ribavirin alters NK cell phenotype and function in patients with chronic hepatitis C.

by Antoaneta A Markova, Ulrike Mihm, Verena Schlaphoff, Sebastian Lunemann, Natalie Filmann, Birgit Bremer, Thomas Berg, Christoph Sarrazin, Stefan Zeuzem, Michael P Manns, Markus Cornberg, Eva Herrmann, Heiner Wedemeyer
Published 2014-01-01

Baseline MELD score predicts hepatic decompensation during antiviral therapy in patients with chronic hepatitis C and advanced cirrhosis.

by Georg Dultz, Martin Seelhof, Eva Herrmann, Martin-Walter Welker, Mireen Friedrich-Rust, Gerlinde Teuber, Bernd Kronenberger, Michael von Wagner, Johannes Vermehren, Christoph Sarrazin, Stefan Zeuzem, Wolf Peter Hofmann
Published 2013-01-01

Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry

by Frank Tacke, Hartwig Klinker, Klaus H. W. Boeker, Uta Merle, Ralph Link, Peter Buggisch, Dietrich Hüppe, Markus Cornberg, Christoph Sarrazin, Heiner Wedemeyer, Thomas Berg, Stefan Mauss, DHC‐R
Published 2022-09-01